291 related articles for article (PubMed ID: 18163338)
1. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum.
Srinivasan S; Mueller J; Suana A; Hemphill A
J Parasitol; 2007 Oct; 93(5):1046-55. PubMed ID: 18163338
[TBL] [Abstract][Full Text] [Related]
2. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
Alaeddine F; Keller N; Leepin A; Hemphill A
J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
[TBL] [Abstract][Full Text] [Related]
3. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Hemphill A
Parasitology; 2010 Feb; 137(2):229-40. PubMed ID: 19835644
[TBL] [Abstract][Full Text] [Related]
6. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.
Monney T; Rütti D; Schorer M; Debache K; Grandgirard D; Leib SL; Hemphill A
Vaccine; 2011 Sep; 29(40):6967-75. PubMed ID: 21787824
[TBL] [Abstract][Full Text] [Related]
7. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.
Debache K; Alaeddine F; Guionaud C; Monney T; Müller J; Strohbusch M; Leib SL; Grandgirard D; Hemphill A
Int J Parasitol; 2009 Oct; 39(12):1373-84. PubMed ID: 19447110
[TBL] [Abstract][Full Text] [Related]
9. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum.
Bartley PM; Wright S; Chianini F; Buxton D; Innes EA
Parasitology; 2008 Jan; 135(Pt 1):13-21. PubMed ID: 17767798
[TBL] [Abstract][Full Text] [Related]
10. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice.
Rojo-Montejo S; Collantes-Fernández E; Regidor-Cerrillo J; Rodríguez-Bertos A; Prenafeta A; Gomez-Bautista M; Ortega-Mora LM
Vet Parasitol; 2011 Feb; 175(3-4):220-9. PubMed ID: 21067865
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum.
Ramamoorthy S; Lindsay DS; Schurig GG; Boyle SM; Duncan RB; Vemulapalli R; Sriranganathan N
J Eukaryot Microbiol; 2006; 53(2):151-6. PubMed ID: 16579818
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations.
Pinitkiatisakul S; Friedman M; Wikman M; Mattsson JG; Lövgren-Bengtsson K; Ståhl S; Lundén A
Vaccine; 2007 May; 25(18):3658-68. PubMed ID: 17280751
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
[TBL] [Abstract][Full Text] [Related]
15. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.
Haldorson GJ; Mathison BA; Wenberg K; Conrad PA; Dubey JP; Trees AJ; Yamane I; Baszler TV
Int J Parasitol; 2005 Nov; 35(13):1407-15. PubMed ID: 16051244
[TBL] [Abstract][Full Text] [Related]
16. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
[TBL] [Abstract][Full Text] [Related]
17. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a Neospora caninum microneme-associated protein (NcMIC4) that exhibits unique lactose-binding properties.
Keller N; Riesen M; Naguleswaran A; Vonlaufen N; Stettler R; Leepin A; Wastling JM; Hemphill A
Infect Immun; 2004 Aug; 72(8):4791-800. PubMed ID: 15271941
[TBL] [Abstract][Full Text] [Related]
19. Intra-cisternal vaccination induces high-level protection against Neospora caninum infection in mice.
Debache K; Hemphill A
Vaccine; 2012 Jun; 30(28):4209-15. PubMed ID: 22537986
[TBL] [Abstract][Full Text] [Related]
20. Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis.
Zhang H; Lee EG; Liao M; Compaore MK; Zhang G; Kawase O; Fujisaki K; Sugimoto C; Nishikawa Y; Xuan X
Mol Biochem Parasitol; 2007 Jun; 153(2):141-8. PubMed ID: 17412435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
